Mumbai, Aug. 5 -- Revenue from operations grew 9.54% year on year (YoY) to Rs 1,710.72 crore in the quarter ended 30 June 2025.

Profit before tax (PBT) was at Rs 190.10 crore in Q1 FY26, up 21.05% from Rs 157.03 crore recorded in the corresponding quarter previous year.

EBIDTA grew 20% YoY to Rs 288 crore while EBIDTA margin stood at 17% during the period under review.

The India Branded Business recorded a 5% year-on-year growth, generating Rs.599 crore in revenue during the quarter. Specialty Therapies, including Gynaecology, Cardiology, Anti-Diabetic, Ophthalmology, and Animal Healthcare segments, demonstrated strong momentum. Additionally, the Anti-infective and Cough & Cold segments matched market performance, supported by robust o...